Baidu
map

Risk of fatigue with PARP inhibitors in cancer patients: a systematic review and meta-analysis of 29 phase II/III randomized controlled trials

Li, J; Zhang, ZF

Li, J (corresponding author), Southwest Minzu Univ, Coll Pharm, 16 South 4th Sect,1st Ring Rd, Chengdu 610041, Sichuan, Peoples R China.

JOURNAL OF CHEMOTHERAPY, ; ():

Abstract

Fatigue was a frequently reported adverse event associated with the use of PARP inhibitors. We performed a systematic review and meta-analysis to full......

Full Text Link


Baidu
map
Baidu
map
Baidu
map